Wed, February 28, 2018
Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018
Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018
Fri, February 16, 2018
Thu, February 15, 2018
Wed, February 14, 2018
Tue, February 13, 2018
Mon, February 12, 2018
Fri, February 9, 2018

Jeffrey Hung Maintained (VYGR) at Buy with Increased Target to $39 on, Feb 21st, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-39-on-feb-21st-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Jeffrey Hung of Morgan Stanley, Maintained "Voyager Therapeutics, Inc." (VYGR) at Buy with Increased Target from $36 to $39 on, Feb 21st, 2018.

Jeffrey has made no other calls on VYGR in the last 4 months.



There are 3 other peers that have a rating on VYGR. Out of the 3 peers that are also analyzing VYGR, 0 agree with Jeffrey's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Jeffrey


  • Dane Leone of "BTIG" Initiated at Strong Buy and Held Target at $32 on, Wednesday, December 20th, 2017
  • Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $35 on, Friday, October 27th, 2017
  • Stanley Elliott of "Stifel" Maintained at Strong Buy with Increased Target to $31 on, Monday, October 23rd, 2017